Useful Links and Guidelines

Pathogen Safety Data Sheets

Pathogen Safety Data Sheets (PSDSs) are technical documents used by individuals working with pathogens in the laboratory.

https://www.canada.ca/en/public-health/services/laboratory-biosafety-biosecurity/pathogen-safety-data-sheets-risk-assessment.html

WHO Laboratory Biosafety Manual ‐ Third Edition

For more than 20 years, since it was first published in 1983, the Laboratory Biosafety Manual has provided practical guidance on biosafety techniques for use in laboratories at all levels.
http://www.who.int/csr/resources/publications/biosafety/WHO_CDS_CSR_LYO_2004_11/en/
http://www.who.int/csr/resources/publications/biosafety/Biosafety7.pdf

WHO Tuberculosis laboratory Biosafety Manual

Laboratory biosafety is the process of applying a combination of administrative controls, containment principles, practices and procedures, safety equipment, emergency preparedness, and facilities to enable laboratory staff to work safely with potentially infectious microorganisms; biosafety also aims at preventing unintentional exposure to pathogens or their accidental release. This manual describes the minimum
biosafety measures that should be implemented at the different levels of tuberculosis (TB) testing laboratories to reduce the risk of a laboratory‐acquired infection.

http://apps.who.int/iris/bitstream/10665/77949/1/9789241504638_eng.pdf?ua=1

Biosafety in Microbiological and Biomedical Laboratories (BMBL) 5th Edition

Biosafety in Microbiological and Biomedical Laboratories (BMBL) quickly became the cornerstone of Biosafety practice and policy in the United States upon first publication in 1984. Historically, the information in this publication has been advisory is nature even though legislation and regulation, in some circumstances, have overtaken it and made compliance with the guidance provided mandatory.

http://www.cdc.gov/biosafety/publications/bmbl5/bmbl.pdf
 

Arthropod Containment Guidelines (ACG)

ACG recommended biosafety levels specific for for arthropods of public health importance. The guidelines are subjected to change based on further consideration of the requirements for containment of arthropods and vectors.

https://www.sc.edu/ehs/Biosafety/Arthropod%20Containment%20Guidelines%20(ACME).pdf

Biosafety Measures in the Clinical Laboratory

Clinical laboratories are special, often unique, work environments that may pose identifiable infectious disease risks to per‐ sons in or near them. These infections have been recognized for many years. In a series of published early surveys, Pike and associates reported over 3,000 cases of laboratory‐acquired infections, including brucellosis, tuberculosis, typhoid, streptococcal infections, and hepatitis. These incidents, along with considerable anecdotal information, suggest that most laboratory‐acquired infections occur as a result of error, accident, or carelessness in the handling of a known pathogen; often the mode of transmission is unknown.

http://labmed.oxfordjournals.org/content/labmed/32/8/435.full.pdf

 

Safe Work Practices in Human and Animal Medical Diagnostic Laboratories: Recommendations of a CDC‐convened, Biosafety Blue Ribbon Panel

Prevention of injuries and occupational‐related infections in U.S. laboratories is a major concern. A previous publication presented biosafety guidelines for laboratories; however, it did not address safety in diagnostic labs in human and animal medicine. In 2008, CDC convened a Blue Ribbon Panel to review safety issues in diagnostic labs. This supplement presents the guidelines developed by this group of experts.

http://www.cdc.gov/mmwr/pdf/other/su6104.pdf

Guidelines for Biosafety Laboratory Competency

These supplementary guidelines for Biosafety laboratory competency, developed on behalf of CDC and the APHL, outline the essential skills, knowledge, and abilities required for working with biologic agents at the three highest Biosafety levels (BSLs) (levels 2, 3, and 4).

https://www.cdc.gov/mmwr/pdf/other/su6002.pdf

Biosafety Guidelines of Bangladesh

These Biosafety guidelines are applicable to all research and development activities of modern biotechnology conducted in laboratories of the government research institutes, state enterprises, universities, international organizations located in Bangladesh, private companies or non‐governmental organizations. It applies to laboratory and field trial, trans‐boundary movement, transit, handling and use of all
GMOs/LMOs that may have adverse effects on the conservation and sustainable use of biological diversity, taking also into account risks to human health.

http://dbtbiosafety.nic.in/act/Bangladesh.pdf
 

Environment conservation rule 1997

Environmental protection is a practice of protecting the natural environment on individual, organization controlled or governmental levels, for the benefit of both the environment and humans. Due to the pressures of over consumption, population and technology, the biophysical environment is being degraded, sometimes permanently. This has been recognized, and governments have begun placing restraints on activities that cause environmental degradation. Following links are the Rules followed in Bangladesh for Environment Conservation.

http://faolex.fao.org/docs/pdf/bgd19918.pdf

http://doe.portal.gov.bd/sites/default/files/files/doe.portal.gov.bd/policies/2d85eb8f_1790_44de_837a_83c59077b39/Environment%20Conservation%20Rule‐1997.pdf
 

Bangladesh Medical Waste Management Guidelines

Bangladesh Medical Waste Management Guidelines was published in 2008 for managing medical waste in Bangladesh.

http://www.doe.gov.bd/site/view/policies/
 

Best Management Practices For Hospital Waste

This document discusses ecology’s environmental management concerns in hospitals. The focus of this document is to address proper management of dangerous waste in hospitals, but some of the concerns affecting water quality are included in this section as well.

https://fortress.wa.gov/ecy/publications/publications/0504013.pdf
 

Interim Guidance for Protecting Workers from Occupational Exposure to Zika Virus

Zika virus is primarily spread through the bites of infected mosquitoes. Mosquitoes can become infected when they bite infected persons and can then spread the Zika virus to other persons they subsequently bite.

http://www.cdc.gov/niosh/topics/outdoor/mosquito‐borne/pdfs/osha‐niosh_fs‐3855_zika_virus_04‐2016.pdf 
 

Online quiz and completion certificate for transportation of hazardous goods

All personnel involved in shipping pathogens must undergo appropriate training for the transport of Category A infectious substances.

http://www.mayomedicallaboratories.com/education/online/dangerousgoods/index.html

MERS and SERS CoV. The information presented here are, collected from pathogens safety data sheet Canada, presented without any change!

WHO has published its interim guidance for laboratory biosafety related to 2019-nCoV/COVID-19/SARS-CoV-2, which is available from the following page and the link below:

https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance

https://www.who.int/docs/default-source/coronaviruse/laboratory-biosafety-novel-coronavirus-version-1-1.pdf?sfvrsn=912a9847_2

Advice for healthcare workers on nCoV

To know the detail about:  Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected, Interim guidance

Interim Clinical Guidance for Management of Patients with Confirmed 2019 Novel Coronavirus (2019-nCoV) Infection

2020 Coronavirus Outbreak Preparedness in Bangladesh

Handbook of COVID-19 Prevention and Treatment

Critical preparedness, readiness and response actions for COVID-19

Responding to community spread of COVID-19